Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics

• Main Authors: Ronaldo Altenburg Gismondi, Ricardo Bedirian, Cesar Romaro Pozzobon, Márcia Cristina Ladeira, Wille Oigman, Mário Fritsch Neves
• Format: Article
• Language: English
• Published: Sociedade Brasileira de Cardiologia (SBC) 2015-01-01
• Series: Arquivos Brasileiros de Cardiologia
• Subjects: Hipertensão; Sistema Renina-Angiotensina/efeitos de drogas; Endotélio/fisiopatologia; Diabetes Mellitus
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2015005050123&lng=en&tlng=en

AbstractBackground:Studies suggest that statins have pleiotropic effects, such as reduction in blood pressure, and improvement in endothelial function and vascular stiffness.Objective:To analyze if prior statin use influences the effect of renin-angiotensin-aldosterone system inhibitors on blood pressure, endothelial function, and vascular stiffness.Methods:Patients with diabetes and hypertension with office systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 80 mmHg had their antihypertensive medications replaced by amlodipine during 6 weeks. They were then randomized to either benazepril or losartan for 12 additional weeks while continuing on amlodipine. Blood pressure (assessed with ambulatory blood pressure monitoring), endothelial function (brachial artery flow-mediated dilation), and vascular stiffness (pulse wave velocity) were evaluated before and after the combined treatment. In this study, a post hoc analysis was performed to compare patients who were or were not on statins (SU and NSU groups, respectively).Results:The SU group presented a greater reduction in the 24-hour systolic blood pressure (from 134 to 122 mmHg, p = 0.007), and in the brachial artery flow-mediated dilation (from 6.5 to 10.9%, p = 0.003) when compared with the NSU group (from 137 to 128 mmHg, p = 0.362, and from 7.5 to 8.3%, p = 0.820). There was no statistically significant difference in pulse wave velocity (SU group: from 9.95 to 9.90 m/s, p = 0.650; NSU group: from 10.65 to 11.05 m/s, p = 0.586).Conclusion:Combined use of statins, amlodipine, and renin-angiotensin-aldosterone system inhibitors improves the antihypertensive response and endothelial function in patients with hypertension and diabetes.